The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2023

Filed:

Aug. 22, 2017
Applicant:

Akeso Pharmaceuticals, Inc., Guangdong, CN;

Inventors:

Baiyong Li, Guangdong, CN;

Yu Xia, Guangdong, CN;

Zhongmin Maxwell Wang, Guangdong, CN;

Peng Zhang, Guangdong, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); G01N 33/577 (2006.01); A61P 35/00 (2006.01); G01N 33/68 (2006.01); C12N 15/62 (2006.01); A61P 7/06 (2006.01); C07K 16/46 (2006.01); A61P 35/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2818 (2013.01); A61K 39/395 (2013.01); A61P 7/06 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07K 16/46 (2013.01); C07K 16/468 (2013.01); C12N 15/62 (2013.01); G01N 33/577 (2013.01); G01N 33/68 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/70521 (2013.01);
Abstract

An anti-CTLA4 (cytotoxic T lymphocyte associated antigen 4) and anti-PD-1 (programmed cell death 1) bifunctional antibody. a pharmaceutical composition thereof and use thereof. Particularly, the anti-CLTA4 and anti-PD-1 bifunctional antibody comprises a first protein functional domain that targets PD-1 and a second protein functional domain that targets CTLA-4. The bifunctional antibody can bind to CTLA-4 and PD-1 specifically, relieve immunosuppression of CTLA4 and PD-1 on an organism specifically, activate T lymphocytes, and thus has good application prospects.


Find Patent Forward Citations

Loading…